EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut microbiota regulates blood‐cerebrospinal fluid barrier function and Aβ pathology

Junhua Xie, Arnout Bruggeman, Clint De Nolf iD, Charysse Vandendriessche iD, Griet Van Imschoot, Elien Van Wonterghem, Lars Vereecke, Roosmarijn E Vandenbroucke iD

The EMBO Journal · 04.09.2023 · 42 (17)

DOI: 10.15252/embj.2022111515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The EMBO Journal, online erschienen am 10.07.2023. Verfasst von Junhua Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: VIB Center for Inflammation Research, Ghent, Belgium. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Alzheimer Disease, Microbiota. Die Arbeit wurde bisher 126-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Fonds Baillet Latour, Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulating evidence indicates that gut microbiota dysbiosis is associated with increased blood–brain barrier (BBB) permeability and contributes to Alzheimer's disease (AD) pathogenesis. In contrast, the influence of gut microbiota on the blood‐cerebrospinal fluid (CSF) barrier has not yet been studied. Here, we report that mice lacking gut microbiota display increased blood‐CSF barrier permeability associated with disorganized tight junctions (TJs), which can be rescued by recolonization with gut microbiota or supplementation with short‐chain fatty acids (SCFAs). Our data reveal that gut microbiota is important not only for the establishment but also for the maintenance of a tight barrier. Also, we report that the vagus nerve plays an important role in this process and that SCFAs can independently tighten the barrier. Administration of SCFAs in App NL‐G‐F mice improved the subcellular localization of TJs at the blood‐CSF barrier, reduced the β‐amyloid (Aβ) burden, and affected microglial phenotype. Altogether, our results suggest that modulating the microbiota and administering SCFAs might have therapeutic potential in AD via blood‐CSF barrier tightening and maintaining microglial activity and Aβ clearance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeAlzheimer DiseaseMicrobiotaMiceAnimalsBlood-Brain BarrierAmyloid beta-PeptidesFatty Acids, Volatile

Stichwörter der Autor:innen

Alzheimer's diseaseblood-cerebrospinal fluid barriergut microbiotashort-chain fatty acidsvagus nerve

Substanzen

Amyloid beta-PeptidesFatty Acids, Volatile

Autor:innen und Institutionen

  • VIB Center for Inflammation Research, Ghent, Belgium.
  • Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
  • Department of Neurology, Ghent University Hospital, Ghent, Belgium.
  • Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
  • Ghent Gut Inflammation Group (GGIG), Ghent University, Ghent, Belgium.

ORCID-Profile: Clint De Nolf, Charysse Vandendriessche, Roosmarijn E Vandenbroucke

Förderung

  • China Scholarship Council
  • Fonds Baillet Latour
  • Fonds Wetenschappelijk Onderzoek
  • Foundation for Alzheimers Research (SAO) Belgium

Zitieren

APA

Xie, J., Bruggeman, A., De Nolf, C., Vandendriessche, C., Van Imschoot, G., Van Wonterghem, E., Vereecke, L., & Vandenbroucke, R. E. (2023). Gut microbiota regulates blood‐cerebrospinal fluid barrier function and Aβ pathology. The EMBO Journal, 42(17). https://doi.org/10.15252/embj.2022111515

Vancouver

Xie J, Bruggeman A, De Nolf C, Vandendriessche C, Van Imschoot G, Van Wonterghem E, et al. Gut microbiota regulates blood‐cerebrospinal fluid barrier function and Aβ pathology. The EMBO Journal. 2023;42(17). doi:10.15252/embj.2022111515

BibTeX
@article{Xie2023,
  author = {Xie, Junhua and Bruggeman, Arnout and De Nolf, Clint and Vandendriessche, Charysse and Van Imschoot, Griet and Van Wonterghem, Elien and Vereecke, Lars and Vandenbroucke, Roosmarijn E},
  title = {Gut microbiota regulates blood‐cerebrospinal fluid barrier function and Aβ pathology},
  journal = {The EMBO Journal},
  year = {2023},
  volume = {42},
  number = {17},
  doi = {10.15252/embj.2022111515}
}
Kostenlos starten →